| 
April 09, 2023
BeiGene is Thursday's top mover after gaining 12.48%
Leading equity indices in the US rose as Nasdaq ended the session at 12,100 after a 0.76% gain. S&P 500 gained 0.36% and closed at 4,105.
Assets that recorded the greatest percentage change in relation to their peers are designated as "Top Movers" with 's most active healthcare stocks listed below.
BeiGene gains 12.48% within $218.26 to $242.38 daily range
The global oncology developer closed Wednesday at $212. Thursday, it gained 12.48% and remained around $238.45. The global biotech company's market cap currently stands at $24.89 billion with an average daily volume of 227,395 shares. So far this year, it has been doing worse than the Nasdaq by 8.28%.
Solid session for Novavax generates 11.46% gain Thursday
Thursday's session pointed in the same direction — the US biotechnology company gained 11.46% and stayed at $8.46 levels. The company has a market cap of $729 million with an average daily trading volume of 5.69 million shares. So far this year, it has been under-performing the Nasdaq by 29.09%.
Nektar Therapeutics closes at 79.12 cents after gaining 8.94%
Nektar Therapeutics lived up to expectations Thursday by maintaining its set course — the US biopharmaceutical company went up to 79.12 cents, gaining 8.94%. Nektar Therapeutics is currently trading with a market cap of $149.72 million with an average daily trading volume of 8.76 million shares.
